Interleukin-1 Blockade With Canakinumab to Improve Exercise Capacity in Patients With Chronic Systolic Heart Failure and Elevated High Sensitivity C-reactive Protein (Hs-CRP)

Clinical trial NCT01900600 · COMPLETED

Trial details

NCT number: NCT01900600
Sponsor: Virginia Commonwealth University
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Prior Acute Myocardial Infarction Evidence of Systemic Inflammation (C Reactive Protein Plasma >2 mg/l)Reduced Left Ventricle Ejection Fraction (<50%)Symptoms of Heart Failure (NYHA Class II-III)

Start date: 2013-04-01
Primary completion: 2015-01-08
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.